ARYA Sciences Acquisition Corp IV

Status: Pre-Deal
U=S
IPO Proceeds, $M $149.5
IPO Date Feb 26, 2021
CEO Adam Stone
Left Lead Goldman Sachs
IPO Cash in Trust 100%
SPAC Tenor 24 months
IPO Sector Healthcare

Life sciences and medical technology in North America and Europe

IPO Geography Global
Target Company TBD
Deal Announced TBD
Deal Size, $M TBD
Deal Geography TBD
Deal Sector TBD
SEC Filings www.sec.gov
ARYD


Sign up for Free Trial

No credit card required

Sign in for more data on ARYA Sciences Acquisition Corp IV:

  • 7 directors & officers
  • 4 filings and events
  • 2 underwriters
  • 60 shareholders (from 13F filings)